---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-000003"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:53:44.866101+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health extends convertible note maturities to March 31, 2023; adds $50K principal to one note

## Summary
- Amendment No. 4 with LGH extends $1.05M note maturity to March 31, 2023; adds $50K to principal, paydown $35K.
- Amendments with three directors and two officers extend their promissory notes to March 31, 2023.
- Amendment with investor Jonathan Lutz extends note maturity to January 31, 2023.
- All other terms and conditions remain unchanged.

## SEC filing metadata
- accession: 0001683168-23-000003
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-000003
- JSON: https://secwatch.observer/filing/0001683168-23-000003.json
- Plain text: https://secwatch.observer/filing/0001683168-23-000003.txt

## Key facts
- Debt Financings
  Odyssey Health, Inc. amended loan with three directors and two officers of the Company maturing March 31, 2023.
  - Instrument: loan
  - Counterparty: three directors and two officers of the Company
  - Maturity: March 31, 2023
  - Event: amendment
  source text: On December 30, 2022, the Company entered into five Promissory Note Amendments (the "Amendments"), to the Promissory Notes entered into December 21, 2021 and December 22, 2021 and as amended April 20, 2022, June 3, 2022 and September 30, 2022, with three directors and two officers of the Company. Pursuant to the Amendments, the parties have agreed to extend the maturity date of the note to March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm
- Debt Financings
  Odyssey Health, Inc. amended loan with Jonathan Lutz maturing January 31, 2023.
  - Instrument: loan
  - Counterparty: Jonathan Lutz
  - Maturity: January 31, 2023
  - Event: amendment
  source text: On December 30, 2022, the Company entered into a Promissory Note Amendment (the "Investor Amendment"), to the Promissory Notes entered into September 21, 2022, with Jonathan Lutz, an accredited investor. Pursuant to the Investor Amendment, the parties have agreed to extend the maturity date of the note to January 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm
- Debt Financings
  Odyssey Health, Inc. amended convertible notes of paydown thirty-five thousand ($35,000) towards the principal amount outstanding and fifty thousand ($50,000) shall be ad with LGH Investments, LLC maturing March 31, 2023.
  - Instrument: convertible notes
  - Principal: paydown thirty-five thousand ($35,000) towards the principal amount outstanding and fifty thousand ($50,000) shall be ad
  - Counterparty: LGH Investments, LLC
  - Maturity: March 31, 2023
  - Event: amendment
  source text: On December 29, 2022, Odyssey Health, Inc., f/k/a Odyssey Group International, Inc. (the "Company"), entered into Amendment No. 4 to the Convertible Promissory Note (the "Amendment") to the Securities Purchase Agreement dated April 5, 2021, with LGH Investments, LLC ("LGH"). Pursuant to the Amendment, the parties have agreed to extend the maturity date of the note to March 31, 2023. As consideration, the Company shall paydown thirty-five thousand ($35,000) towards the principal amount outstanding and fifty thousand ($50,000) shall be added to the principal amount outstanding.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm
- Material Agreements
  Odyssey Health, Inc. amended Promissory Note Amendment with Jonathan Lutz, an accredited investor (effective 2022-12-30).
  - Action: amendment
  - Counterparty: Jonathan Lutz, an accredited investor
  - Effective: 2022-12-30
  source text: On December 30, 2022, the Company entered into a Promissory Note Amendment (the “Investor Amendment”), to the Promissory Notes entered into September 21, 2022, with Jonathan Lutz, an accredited investor.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm
- Material Agreements
  Odyssey Health, Inc. amended Amendment No. 4 to the Convertible Promissory Note with LGH Investments, LLC (effective 2022-12-29).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: LGH Investments, LLC
  - Effective: 2022-12-29
  source text: On December 29, 2022, Odyssey Health, Inc., f/k/a Odyssey Group International, Inc. (the “Company”), entered into Amendment No. 4 to the Convertible Promissory Note (the “Amendment”) to the Securities Purchase Agreement dated April 5, 2021, with LGH Investments, LLC (“LGH”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823000003/0001683168-23-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.